Clinical Trials Browser

Familial ependymoma, Thyroid Cancer, Papillary, Mesothelioma, Malignant, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Medulloblastoma, Oligodendroglioma, Pheochromocytoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Adenocarcinoma, Follicular, Adrenocortical Carcinoma, Carcinoma, Medullary, Glioma, Subependymal, Gliosarcoma, Optic Nerve Glioma, Thyroid Carcinoma, Anaplastic

NCT00331955 2013-07-02

Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00079014 2013-05-16

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00020124 2012-03-15

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

Clinical Trials

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs